Bevacizumab - Latest Advances

Birdshot Chorioretinopathy with Double-Layer Sign and Choroidal Neovascularization: A Single-Centre Analysis.

Journal: Ocular immunology and inflammation

Published: December 15, 2025

Corrigendum to "Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model" [Heliyon Volume 9, Issue 5, May 2023, Article e16217].

Journal: Heliyon

Published: December 15, 2025

Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: December 13, 2025

Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.

Journal: Nature communications

Published: December 12, 2025

Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection.

Journal: mAbs

Published: December 12, 2025

Molecularly guided precision therapy in metastatic adamantinoma: a case report.

Journal: Personalized medicine

Published: December 10, 2025

Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal Cancer.

Journal: JAMA network open

Published: December 04, 2025

Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 03, 2025

Antifibrotics in glaucoma surgery: current practices and future directions.

Journal: Current opinion in ophthalmology

Published: December 02, 2025

Beta-blocker use and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis.

Journal: The Journal of international medical research

Published: November 27, 2025

Anticancer drug-induced nephrotoxicity: biopsy-proven patterns and outcomes across chemotherapy, targeted therapy, and immune checkpoint inhibitors.

Journal: Renal failure

Published: November 25, 2025

Management of MOG antibody-associated disease by pembrolizumab and radiation myelopathy in an elderly patient: A case report and literature review.

Journal: Human vaccines & immunotherapeutics

Published: November 25, 2025

Filters

Birdshot Chorioretinopathy with Double-Layer Sign and Choroidal Neovascularization: A Single-Centre Analysis.

Birdshot Chorioretinopathy with Double-Layer Sign and Choroidal Neovascularization: A Single-Centre Analysis.

Corrigendum to "Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model" [Heliyon Volume 9, Issue 5, May 2023, Article e16217].

Corrigendum to "Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model" [Heliyon Volume 9, Issue 5, May 2023, Article e16217].

Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study.

Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study.

Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.

Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.

Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection.

Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection.

Molecularly guided precision therapy in metastatic adamantinoma: a case report.

Molecularly guided precision therapy in metastatic adamantinoma: a case report.

Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal Cancer.

Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal Cancer.

Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Antifibrotics in glaucoma surgery: current practices and future directions.

Antifibrotics in glaucoma surgery: current practices and future directions.

Beta-blocker use and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis.

Beta-blocker use and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis.

Anticancer drug-induced nephrotoxicity: biopsy-proven patterns and outcomes across chemotherapy, targeted therapy, and immune checkpoint inhibitors.

Anticancer drug-induced nephrotoxicity: biopsy-proven patterns and outcomes across chemotherapy, targeted therapy, and immune checkpoint inhibitors.

Management of MOG antibody-associated disease by pembrolizumab and radiation myelopathy in an elderly patient: A case report and literature review.

Management of MOG antibody-associated disease by pembrolizumab and radiation myelopathy in an elderly patient: A case report and literature review.